Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
18162 | 501 | 25.5 | 54% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | DICLOFENAC EPOLAMINE | Author keyword | 13 | 80% | 2% | 8 |
2 | DICLOFENAC SALTS | Author keyword | 7 | 67% | 1% | 6 |
3 | TOPICAL DICLOFENAC | Author keyword | 5 | 63% | 1% | 5 |
4 | TOPICAL NSAID | Author keyword | 4 | 67% | 1% | 4 |
5 | DICLOFENAC N 2 HYDROXYETHYLPYRROLIDINE | Author keyword | 3 | 100% | 1% | 3 |
6 | IDROCILAMIDE | Author keyword | 3 | 100% | 1% | 3 |
7 | STUDI FIS MACROMOL | Address | 3 | 100% | 1% | 3 |
8 | CAS 15687 27 1 | Author keyword | 3 | 33% | 2% | 8 |
9 | TOPICAL NSAIDS | Author keyword | 3 | 38% | 1% | 6 |
10 | TOPICAL PATCH | Author keyword | 3 | 50% | 1% | 4 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | DICLOFENAC EPOLAMINE | 13 | 80% | 2% | 8 | Search DICLOFENAC+EPOLAMINE | Search DICLOFENAC+EPOLAMINE |
2 | DICLOFENAC SALTS | 7 | 67% | 1% | 6 | Search DICLOFENAC+SALTS | Search DICLOFENAC+SALTS |
3 | TOPICAL DICLOFENAC | 5 | 63% | 1% | 5 | Search TOPICAL+DICLOFENAC | Search TOPICAL+DICLOFENAC |
4 | TOPICAL NSAID | 4 | 67% | 1% | 4 | Search TOPICAL+NSAID | Search TOPICAL+NSAID |
5 | DICLOFENAC N 2 HYDROXYETHYLPYRROLIDINE | 3 | 100% | 1% | 3 | Search DICLOFENAC+N+2+HYDROXYETHYLPYRROLIDINE | Search DICLOFENAC+N+2+HYDROXYETHYLPYRROLIDINE |
6 | IDROCILAMIDE | 3 | 100% | 1% | 3 | Search IDROCILAMIDE | Search IDROCILAMIDE |
7 | CAS 15687 27 1 | 3 | 33% | 2% | 8 | Search CAS+15687+27+1 | Search CAS+15687+27+1 |
8 | TOPICAL NSAIDS | 3 | 38% | 1% | 6 | Search TOPICAL+NSAIDS | Search TOPICAL+NSAIDS |
9 | TOPICAL PATCH | 3 | 50% | 1% | 4 | Search TOPICAL+PATCH | Search TOPICAL+PATCH |
10 | HYDRATE FORMS | 2 | 67% | 0% | 2 | Search HYDRATE+FORMS | Search HYDRATE+FORMS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DHEP PLASTERS | 49 | 94% | 3% | 17 |
2 | ORAL DICLOFENAC | 11 | 60% | 2% | 12 |
3 | ACTION TRANSCUTANEOUS FLURBIPROFEN | 7 | 67% | 1% | 6 |
4 | DICLOFENAC SOLUTION | 6 | 71% | 1% | 5 |
5 | 2 2 6 DICHLOROPHENYLAMINOPHENYLACETATE | 6 | 100% | 1% | 4 |
6 | PERCUTANEOUS KINETICS | 6 | 100% | 1% | 4 |
7 | DICLOFENAC SODIUM GEL | 5 | 45% | 2% | 9 |
8 | 5 PERCENT IBUPROFEN CREAM | 4 | 75% | 1% | 3 |
9 | EPOLAMINE | 4 | 75% | 1% | 3 |
10 | PIROXICAM GEL | 4 | 75% | 1% | 3 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Topical NSAIDs for chronic musculoskeletal pain in adults | 2012 | 11 | 59 | 76% |
Topical NSAIDs for acute pain in adults | 2010 | 20 | 42 | 74% |
Effectiveness and Safety of Topical Versus Oral Nonsteroidal Anti-inflammatory Drugs: A Comprehensive Review | 2013 | 5 | 34 | 68% |
Safety profile of topical diclofenac: a meta-analysis of blinded, randomized, controlled trials in musculoskeletal conditions | 2011 | 12 | 50 | 68% |
Topical NSAID Therapy for Musculoskeletal Pain | 2010 | 31 | 59 | 46% |
Topical diclofenac and its role in pain and inflammation: an evidence-based review | 2008 | 42 | 62 | 52% |
Adverse Effects of Topical Nonsteroidal Antiinflammatory Drugs in Older Adults with Osteoarthritis: A Systematic Literature Review | 2010 | 18 | 43 | 65% |
Topical Analgesics in the Management of Acute and Chronic Pain | 2013 | 15 | 106 | 25% |
Topical Therapies for Osteoarthritis | 2011 | 19 | 89 | 39% |
Oral versus topical NSAIDs in rheumatic diseases - A comparison | 2000 | 142 | 71 | 48% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | STUDI FIS MACROMOL | 3 | 100% | 0.6% | 3 |
2 | DERMOPHARMACOL COSMETOL UNIT | 1 | 50% | 0.2% | 1 |
3 | FOR STELLE GESUNDHEITSOKON GESUNDHEITSSYST F | 1 | 50% | 0.2% | 1 |
4 | HPT ARTS RYK SCI | 1 | 50% | 0.2% | 1 |
5 | IST BRUZZONE | 1 | 50% | 0.2% | 1 |
6 | SKOKIE EVANSTON HOSP | 1 | 50% | 0.2% | 1 |
7 | UNIV ESTADUAL JULIO DE MESQUITA FILHO | 1 | 50% | 0.2% | 1 |
8 | UNIV FED ACRE | 1 | 50% | 0.2% | 1 |
9 | DATA MANAGEMENT STAT UNIT | 1 | 29% | 0.4% | 2 |
10 | CHRON PAIN CARE | 0 | 33% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000175578 | COMFREY//SYMPHYTUM HERB EXTRACT//BORC IBST |
2 | 0.0000151765 | ACECLOFENAC//MEFENAMIC ACID//CAS 15307 86 5 |
3 | 0.0000112399 | MUCOPOLYSACCHARIDE POLYSULFATE//CAS 530 78 9//PERFUSED PIG EAR |
4 | 0.0000088200 | NSAIDS//COXIBS//ROFECOXIB |
5 | 0.0000078558 | PERCUTANEOUS ABSORPTION//PENETRATION ENHANCER//PENETRATION ENHANCERS |
6 | 0.0000074712 | CHIRAL INVERSION//DEXIBUPROFEN//FLOBUFEN |
7 | 0.0000068739 | METHYLSULFONYLMETHANE//DIMETHYL SULFONE//LORANTHUS FERRUGINEUS |
8 | 0.0000059557 | CS 670//LOXOPROFEN//ALPHA BETA KETOALKENE |
9 | 0.0000056459 | IONTOPHORESIS//SONOPHORESIS//REVERSE IONTOPHORESIS |
10 | 0.0000055891 | MONDORS DISEASE//SUPERFICIAL VEIN THROMBOSIS//SUPERFICIAL THROMBOPHLEBITIS |